Comments for Access Pharma (OTC:ACCP) CEO Interview: Updates and Outlook at http://www.biomedreports.com , comment 1 to 3 out of 3 comments http://www.biomedreports.com Wed, 08 Feb 2012 16:51:33 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200908297262/access-pharma-otcaccp-ceo-interview-updates-and-outlook.html#comment-728 No, see my report and CEO interviews for the upcoming catalysts, many of which are expected by year-end. Also, the stock has more than doubled (even with recent pullback) since May. - Mike Havrilla Sat, 29 Aug 2009 09:23:56 +0100 http://www.biomedreports.com/200908297262/access-pharma-otcaccp-ceo-interview-updates-and-outlook.html#comment-727 Hi Mike I have a question for you, I have been long on ACCP since the PPS was 1.95, I know that you are long this name too, is the recent drop in the price of any concern to you? seems like the price is going down for no apparent reason, your insight would be really helpful. Thanks. Rahul - Rahul Agarwal Sat, 29 Aug 2009 09:11:48 +0100 http://www.biomedreports.com/200908297262/access-pharma-otcaccp-ceo-interview-updates-and-outlook.html#comment-726 ACCP has a bright future. MuGard will be a blockbuster as well as a fantastic product for cancer chemo/radiation patients. Keep up the good work CEO DAvis. We shareholders are excited! - Gloria Sat, 29 Aug 2009 08:35:10 +0100